BioSpace News Archive

Genetown

PerkinElmer’s Horizon Discovery CHOSOURCE™ Platform Expanding To Include CHO-K1 ADCC+ Expression Cell Line for Development of Therapeutic Antibodies in Oncology, Infectious Disease and Autoimmune Conditions

PerkinElmer Inc today announced that its Horizon Discovery CHOSOURCE™ platform is expanding to include a new expression cell line, CHO-K1 ADCC+ .

October 6, 2021
·
3 min read
Psygen Announces That Psilocybin from Its Patent-Pending Process Has Been Used in Human Trial

Psygen is excited to announce that psilocybin recently used in a clinical trial was manufactured using Psygen’s patent-pending synthetic method.

October 6, 2021
·
4 min read
Drug Development

Defence Therapeutics Prepares for Phase I Trial to Test Its DC Cancer Vaccine, AccuVAC-D002, Against Melanoma

Defence has successfully exploited the use of its AccumTM technology platform to develop a large pipeline of products in immune-oncology and infectious diseases.

October 6, 2021
·
3 min read
Kazia Therapeutics to Present at LD Micro Main Event

Kazia Therapeutics Limited is pleased to announce that CEO, Dr James Garner , will be presenting at the LD Micro Main Event, to be held virtually and in person from 12-14 October 2021

October 6, 2021
·
2 min read
Biotech Bay

Twin Health Raises $140M Series C to Scale Its Groundbreaking Whole Body Digital Twin™ Service Enabling Reversal and Prevention of Chronic Metabolic Disease

Twin Health, makers of the Whole Body Digital Twin™ precision health service, today announced $140 million in Series C funding as it scales its service in the U.S. and globally.

October 6, 2021
·
6 min read
Zivo Bioscience, Inc. to Participate in the Global AgTech Virtual Conference Presented by Maxim Group LLC and hosted by M-Vest on October 14, 2021 at 10 A.M. EDT

Zivo Bioscience, Inc. announced today that Company CEO Andrew A. Dahl has been invited to present at the Global AgTech Virtual Conference, presented by Maxim Group LLC and hosted by M-Vest, on October 14, 2021 at 10 a.m. EDT.

October 6, 2021
·
3 min read
Pharm Country

Citius Pharmaceuticals to Present at Upcoming October Investor Conferences

Citius Pharmaceuticals, Inc. today announced that it will present at two investor conferences during the month of October 2021.

October 6, 2021
·
2 min read
Pharm Country

Todos Medical Announces Positive Data in Hospitalized and Outpatient Setting for TolloTest™, a Novel SARS-CoV-2 3CL Protease Biomarker Assay

Todos Medical, Ltd. (“Todos Medical”) (OTCQB: TOMDF), today announced positive clinical validation data for its 3CL protease biomarker assay TolloTest™ in a clinical study evaluating its sensitivity compared with PCR in hospitalized COVID-19 patients.

October 6, 2021
·
11 min read
Janssen Announces Novel Mechanism of Action that Shows Promise Against Dengue in Data Published in Nature

The Janssen Pharmaceutical Companies of Johnson & Johnson (Janssen) announced today, the publication of new preclinical data in the journal Nature showing that an early-stage compound with a novel mechanism of action could potentially treat all serotypes of dengue fever and provide a period of protection against acquiring the dengue virus.

October 6, 2021
·
9 min read
Biotech Bay

Flightpath Licenses the First Antibiotic that Selectively Kills Lyme Disease Spirochetes

Flightpath Biosciences, Inc, a biotechnology company advancing microbiome-sparing therapeutics and diagnostics for infectious diseases, licensed a developmental antibiotic FP-100 acting selectively against a range of spirochetal pathogens from Northeastern University.

October 6, 2021
·
3 min read